This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Clinical

Extra catch with neonatal screening for CCHDs
Foreword
NICE sets out draft recommendations for Repatha® in Final Appraisal Determination
NICE sets out draft recommendations for Repatha® in Final Appraisal Determination
Reducing cardiovascular disease by 2025
UMC Utrecht is first hospital to expand diagnostic capabilities with Philips IQon Spectral CT System
UMC Utrecht is first hospital to expand diagnostic capabilities with Philips IQon Spectral CT System
Olympus and King’s College Hospital to deliver Britain’s largest 3D surgical endoscopy installation
Olympus and King’s College Hospital to deliver Britain’s largest 3D surgical endoscopy installation
NICE gives green light to new drug set to benefit 100,000 people with common heart condition
NICE gives green light to new drug set to benefit 100,000 people with common heart condition
Boston Scientific announces CE mark for MRI labelling of EMBLEM™ S-ICD Systems
Boston Scientific announces CE mark for MRI labelling of EMBLEM™ S-ICD Systems
EADV launches Global Call to Action to protect outdoor workers from skin cancer caused by the sun
EADV launches Global Call to Action to protect outdoor workers from skin cancer caused by the sun
Siemens develops e-health application for German Radiology Network
Siemens develops e-health application for German Radiology Network
Kymab and Heptares enter strategic collaboration to develop novel antibody therapeutics
Kymab and Heptares enter strategic collaboration to develop novel antibody therapeutics
Selvita files IND application for its novel, dual PIM/FLT3 inhibitor in AML
Selvita files IND application for its novel, dual PIM/FLT3 inhibitor in AML


Popular articles

Aggressive end-of-life care more common in nursing home compared to community residents
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora